Home / Topics / biotechnology

biotechnology Podcasts

8 episodes about biotechnology

Inside Gilead Sciences: Leading in virology while diversifying into oncology and inflammation artwork

Inside Gilead Sciences: Leading in virology while diversifying into oncology and inflammation
Gilead Sciences Inc. (GILD)
• 48:38 •Ep 17 •Inside the Business •▶ Play on Apple
Gilead Sciences Tech Radar: Acquiring in vivo cell therapy platforms to reduce costs artwork

Gilead Sciences Tech Radar: Acquiring in vivo cell therapy platforms to reduce costs
Gilead Sciences Inc. (GILD)
• 18:51 •Ep 14 •Business Tech Radar •▶ Play on Apple
Inside Amgen: A biologics leader driving volume growth through cardiometabolic and rare disease innovation artwork

Inside Amgen: A biologics leader driving volume growth through cardiometabolic and rare disease innovation
Amgen (AMGN)
• 29:06 •Ep 13 •Inside the Business •▶ Play on Apple
Amgen Tech Radar: Amgen is deploying artificial intelligence to accelerate therapeutic discovery artwork

Amgen Tech Radar: Amgen is deploying artificial intelligence to accelerate therapeutic discovery
Amgen (AMGN)
• 20:22 •Ep 10 •Business Tech Radar •▶ Play on Apple
ImmunityBio, Inc. Announced Full Year 2025 Earnings on March 3, 2026, Reporting "Full year net product revenue for ANKTIVA was $113 million" artwork

ImmunityBio, Inc. Announced Full Year 2025 Earnings on March 3, 2026, Reporting "Full year net product revenue for ANKTIVA was $113 million"
ImmunityBio Inc. (IBRX)
• 18:00 •Ep 51 •The Earnings Debate •▶ Play on Apple
Natera, Inc. (NTRA) Announced Q4 2025 Earnings on February 26, 2026, Reporting "roughly $666 million of revenue in the quarter" artwork

Natera, Inc. (NTRA) Announced Q4 2025 Earnings on February 26, 2026, Reporting "roughly $666 million of revenue in the quarter"
Natera Inc. (NTRA)
• 10:22 •Ep 43 •The Earnings Debate •▶ Play on Apple
Ginkgo Bioworks Holdings, Inc. (DNA) Announced Q4 2025 Earnings on February 26, 2026, Reporting "Cell engineering revenue was $26 million in the fourth quarter of 2025" artwork

Ginkgo Bioworks Holdings, Inc. (DNA) Announced Q4 2025 Earnings on February 26, 2026, Reporting "Cell engineering revenue was $26 million in the fourth quarter of 2025"
Ginkgo Bioworks Holdings Inc. (DNA)
• 17:11 •Ep 41 •The Earnings Debate •▶ Play on Apple
BeOne Medicines AG Announced Q4 2025 Earnings on February 26, 2026, Reporting "Product revenue reached $1.5 billion in the fourth quarter". artwork

BeOne Medicines AG Announced Q4 2025 Earnings on February 26, 2026, Reporting "Product revenue reached $1.5 billion in the fourth quarter".
BeOne Medicines AG (ONC)
• 10:46 •Ep 37 •The Earnings Debate •▶ Play on Apple